Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Annals of Hematology|September 16, 2025
Revisiting hepatitis B vaccination in children with transfusion-dependent thalassemiaAngga Wirahmadi, Ludi Dhyani Rahmartani, Pustika Amalia WahidiyatGlobal Epidemiology|January 29, 2024
Seroconversion among children with HBsAg-positive mothers in Indonesia and factors affecting the anti-HBs titersAngga Wirahmadi, Hartono Gunardi, Bernie Endyarni Medise, et al.Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|February 8, 2024
Immunization Simulation Using Actual-Size Infant Manikins for Medical Students in Indonesia: A Quasi-Experimental StudyHartono Gunardi, Angga Wirahmadi, Bernie Endyarni Medise, et al.BMC Pediatrics|October 16, 2020
A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2-11 years: a phase II preliminary reportBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 1, 2020
One-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate VaccineBernie Endyarni Medise, Soedjatmiko Soedjatmiko, Hartono Gunardi, et al.Vaccines|April 27, 2024
Immunogenicity Assessment of the SARS-CoV-2 Protein Subunit Recombinant Vaccine (CoV2-IB 0322) in a Substudy of a Phase 3 Trial in IndonesiaSharifah Shakinah, Muhammad Hafiz Aini, Rini Sekartini, et al.Human Vaccines & Immunotherapeutics|May 17, 2025
Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac®) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled studyYetty Movieta Nency, Rini Sekartini, Angga Wirahmadi, et al.Tropical Diseases, Travel Medicine and Vaccines|January 31, 2024
A phase II clinical trial of a Vi-DT typhoid conjugate vaccine in healthy Indonesian adolescents and adults: one-month evaluation of safety and immunogenicitySukamto Koesnoe, Bernie Endyarni Medise, Iris Rengganis, et al.Pageof 1